The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...
Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit ...
Repatha: the frontline of US price battles Amgen's Repatha became the first in the new class of cholesterol-lowering PCSK9 inhibitor drugs to gain approval this year, getting the nod in Europe in ...
Examining US policy to curb drug use since the 1890s, Coates, in an op-ed piece for The Conversion, said past US government ...
Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs ...
The result is that, by 2015, US spending on pharmaceuticals exceeded $1,000 per person and was between 30% and 190% higher than nine European ... medicines prices. And, while the US drugs system ...
The trade threats could reduce exports to the United States and dampen investment in Europe, dealing a blow to growth at a ...
President Trump said that he's announcing increases on U.S. tariffs to match the tax rates that other countries charge on ...